Found 88 matching trials
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age PHASE3 This present study, randomized, single-blind, dose-ranging, multicenter stu...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population NA This is a laboratory-blinded study in healthy toddlers, children, and teena...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya PHASE2 In 2012, the WHO Strategic Advisory Group of Experts (SAGE) concluded that ...
Show More Location
Siaya District Hospital
Learn More & Join Trial
H1N1 Vaccine at Two Dose Levels in HIV Positive Adults PHASE2 The purpose of this study is to see how the body reacts to different streng...
Show More Location
University of Iowa
Learn More & Join Trial
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years) PHASE3 This study will evaluate the safety and immunogenicity of different combina...
Show More Location
Instituto de Atencion Pediatrica, Avenida 0-2 Calle 22, Paseo Colon del Restaurante La, Bastilla 50 metros Sur, Edificio 5.
Learn More & Join Trial
Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates PHASE1 This is a Phase 1, randomized, controlled, dose-ranging clinical trial to a...
Show More Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Learn More & Join Trial
Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age PHASE3 The hypothesis for this trial is that the incidence of a pre-defined compos...
Show More Location
Genova Clinical Research
Learn More & Join Trial
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam PHASE3 This was an extensive, double-blind, randomized, placebo-controlled phase 3...
Show More Learn More & Join Trial
Age and Response to Flu Vaccines PHASE4 The study will be designed as a prospective surveillance of the immune resp...
Show More Location
Rochester General Hospital - Infectious Disease Unit
Learn More & Join Trial
Development of Childhood Anti-Influenza Immunity PHASE4 This study is a prospective surveillance of the immune response to seasonal...
Show More Location
University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases
Learn More & Join Trial